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Abstract:
Helicobacter pylori is a spiral Gram-negative bacterium associated with inflammation of the gastric mucosa,
peptic ulcer, and gastric adenocarcinoma; it is one of the leading causes of cancer death worldwide. Treatment
prescribed to patients with gastric ulcer has failed in many cases mainly due to antibiotic resistance and important
side effects such as taste disturbances, vaginal candidiasis, and pseudomembranous colitis. Interest in botanical
medicine is increasing as a viable alternative to the traditional one. Plant leaves of the Asteraceae family are
used to treat diarrhea, ulcers and rheumatism. The aim of this study was to evaluate the activity of aqueous and
methanolic extracts from plants of the Asteraceae family against H. pylori growth in vitro, using the colorimetric
tetrazolium bromide (MTT) reduction assay. We observed that methanolic extracts from plants of the Asteraceae
family showed up to 82% H. pylori growth inhibition (MIC at 500 μg/mL).The results of the present study contribute
to the body of knowledge  of medicinal plants with antimicrobial potential, particularly against H. pylori.
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INTRODUCTION
H. pylori infects and colonizes the human stomach in 50% of the world’s population (Hongying et al.,
2014). Chronic infection in the human stomach is characterized by chronic inflammation. The develop-
ment of gastric adenocarcinoma, particularly of the intestinal type, is preceded by the development of
chronic gastritis, atrophic gastritis, intestinal metaplasia, and dysplasia. In developing countries, 70 to
90% of the population becomes infected before 10 years of age and more than 80% of adults and 50%
of children are colonized by H. pylori compared with 30% of adults and 10% of children in developed
countries (Dunn et al., 1997, Dye et al., 2002). Researchers have mentioned the oral cavity as the main
reservoir of intragastric H. pylori and it is likely that oral health is directly related to infection or reinfection
with H. pylori (Cover et al., 1995). H. pylori has been detected in saliva, plaque and periodontal disease
patients by PCR, culture, urease test; this organism can promote the development of lesions of the oral
mucosa, particularly recurring ulcer disease and lesions of the oral mucosa (Rlgglo and Lennon, 1999;
Nguyen et al., 1993). In México, seroprevalence of H. pylori is higher than 50% (Alvarado-Esquivel
et al., 2013). The first-line treatment option for H. pylori consists of a 7 to 10 days regimen with proton-
pump inhibitor (PPI), plus amoxicillin, and clarithromycin (Alahdab et al., 2014).The use of clarithromycin
increases resistance to H. pylori (Wu et al., 2014). Treatment prescribed to patients with gastric ulcer
fail in many cases mainly due to antibiotic resistance, in addition to induced side effects. Interest in bo-
tanical medicine has increased in recent years, physicians and people seem to show preference for
products that contain “natural extracts” instead of products based on “synthetic” substances (Borchers
et al., 2000, Torrado-Truiti et al., 2003) The first report of plants  against H. pylori was made in 1991
(Cassel-Beraud et al.,1991). There are reports of methanol and aqueous extracts of Mexican plants
that have inhibitory effect against H. pylori (Castillo-Juárez et al., 2009).The plant compounds including
polyphenols, flavonoids, quinones, coumarins, terpenoids and alkaloids.The  anti-H. pylori action me-
chanism, including inhibition of enzymatic(urease, DNA gyrase, dihydrofolate reductase, N-acetyltrans-
ferase, and myeloperoxidase) and anti-adhesion activities, high redox potential and
hydrophilic/hydrophobic natures of compounds (Wang, 2014). The aim of this study was to evaluate
aqueous and  methanol plants extracts using the MTT tetrazolium reduction assay as a viability test to
assess direct effects of these plant extracts against H. pylori growth in vitro.
Materials and Methods
Five grams of each sample were used to prepare the extracts. For aqueous extracts, the plants were
boiled for 10 min with 80 mL of purified water filtered and then lyophilized in freeze dry system (LAB-
CONCO Corp., Kansas City, MI) for about four hours. Once the sample was obtained the amount of
extracts was calculated. In the case of methanol extracts the material was extracted for 72 hours in 80
mL of methanol. After filtration the extracts were evaporated in a Speed Vac (Milford, MA). The plants
screened in the present study were Persea americana Mill (Lauraceae), Pachycereus marginatus (DC.)
Britton & Rose, a plant of the Asteraceae family (its use is in the process of patenting), Ibervillea sonorae
Green, and Phoenix dactylifera Linn.
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Bacterial strain and culture conditions
H. pylori standard strain ATCC 43504 was grown on Brucella broth for a day at 37°C. The  strain was identified
by Gram staining morphology and biochemical positive tests for catalase and urease.
Minimum inhibitory concentration (MIC) determinations
The aqueous and methanol extracts were tested by MTT tetrazolium reduction assay in 96-flat well microplates.
The extracts were dissolved in Brucella broth to obtain a final concentration 7.8, 15.6, 31.2, 62.5,125, 250, and
500 μg/mL. A volume of 50 μL of H. pylori (2.5x105 bacteria/mL) was placed in the plate wells and incubated.
The MIC was determined using the MTT reduction assay, being the lowest concentration of the extracts in the
plate with no bacterial growth. Before extracts were incubated, we added 15 μL of MTT  and incubated for 15
min, then  80 μL of DMSO were added to dissolve the formazan crystals. The absorbances were measured in a
microplate reader at 570 nm (DTX 800/880 Multimode Detectors, Fullerton, CA). All the experiments were per-
formed in triplicate and repeated at least three times. Tetracyclin was used as a positive control.
Results
Methanolic and aqueous extracts of 5 different plants were tested in vitro for their anti H. pylori activity. No
aqueous extract of the 5 plants showed in vitro effect against H.pylori ATCC 43504. Only methanolic  extracts
from plants of the Asteraceae family showed inhibitory effect against H. pylori. Such results are shown in Figure
1. The vehicle control did not affect H. pylori viability.
Figure 1. Inhibitory effect of methanol plant leaves extract of a plant of the Asteraceae family.
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As seen in Figure 1, the Asteraceae plant methanolic extracts showed up to 82.3% growth inhibition of H. pylori
ATCC 43504 at a concentration of 500 μg/mL (p<0.05), and the growth inhibition activity was in a concentration-
dependent manner.
Discussion
The beneficial medicinal effects of plant materials typically result from the combinations of secondary products
present in the plant. In plants, these compounds are mostly secondary metabolites such as alkaloids, steroids,
tannins, and phenol compounds, which are synthesized and deposited in specific parts or in all parts of the plant
(Parekh et al., 2005).
Although our aqueous extracts of Persea americana Mill (Lauraceae), Pachycereus marginatus (DC.) Britton &
Rose, a plant of the Asteraceae family, Ibervillea sonorae Green, and Phoenix dactylifera Linn did not affect H.
pylori viability, authors such as Castillo et al., 2013, reported anti-Helicobacter pylori activity from aqueous extracts
of Persea americana Mill with a minimum inhibitory concentration (MIC) > 1000 μg/mL tested with the agar dilution
method.
Methanolic extracts of plants used in this work have previously been tested against  H. pylori. The MIC of Ibervillea
sonorae Green against H. pylori is reported of 200 to 400 μg/mL (Robles-Zepeda et al., 2011). Also, methanol
extract of Persea americana Mill has been reported as active with a MIC <7.5 μg/mL tested with the broth dilution
method (Castillo et al., 2013).
Asteraceae plants have been reported to contain essential oils, flavonoids (Wollenweber et al., 1981), among
other substances, and possess antimicrobial and antitumor activities.
Our Asteraceae plant methanolic extracts showed a growth inhibition of H. pylori ATCC 43504 at a concentration
of 500μg/mL, and the activity was in a concentration-dependent manner. However the results obtained in this re-
search can not be compared with others due to the bioassay employed. The active concentrations used in the
present study can be considered high, nevertheless there are active components which can inhibit the growth of
the bacteria.
The MTT reduction assay was standardized in order to test the activity anti-Helicobacter pylori of plants. It is
possible that during the extraction method or when the plants were boiled some trace amounts of compounds
evaporated.
Conclusions:
The methanolic extracts from a plant of the Asteraceae family showed up to 82.3% H. pylori growth inhibition at
a concentration of 500μg/mL, which warrants further studies on diverse in vitro and in vivo parameters. 
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